aTyr Pharma, Inc. (ATYR)
NASDAQ·Healthcare·Biotechnology
$5.93
-6.61%
Mkt Cap $15.57M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
Implied Upside
-13.5%
Consensus $5.13 vs current $5.93
NASDAQ·Healthcare·Biotechnology
$5.93
-6.61%
Mkt Cap $15.57M
Buy
1
Hold
1
Sell
0
Price Target (4 analysts)
$5.13
Range $1.00 – $17.00
-13.5%
Consensus $5.13 vs current $5.93